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on Nigeria) and implications for regional
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Abstract
Background: Despite mortality from breast cancer in Africa being higher than in high income countries, breast
cancer has not been extensively studied in the region. The aim of this paper was to highlight the rising burden of
breast cancer with an emphasis on sub-Saharan Africa as well as trends, characteristics, controversies and their
implications for regional development.
Methodology: A review of published studies and documents was conducted in Medline, Scopus, Pubmed and
Google using combinations of key words-breast neoplasm, breast cancer, cancer, incidence, mortality, Africa, Nigeria.
Graphical and frequency analyses were carried out on some of the incidence and mortality figures retrieved from
published papers and the GLOBOCAN website.
Findings: Globally, about 25% and 15% of all new cancer cases and cancer deaths respectively among females were due to
breast cancer. Africa currently had the highest age-standardized breast cancer mortality rate globally, with the highest
incidence rates being recorded within the sub-Saharan African sub-region. Incidence trends such as inherently aggressive
tumour and younger age profile had been subject to controversies. Certain factors such as westernized diet, urbanization
and possibly increasing awareness had been implicated, though their specific contributions were yet to be fully established.
Conclusion: Unless urgent action is taken, breast cancer will compound sub-Saharan Africa’s disease burden, increase
poverty and gender inequality as well as reverse the current global gains against maternal and neonatal mortality.
Keywords: Breast cancer, Incidence, Mortality, Africa, Nigeria
Background
Cancer can occur in different anatomical sites in the
body. Its incidence and mortality differ across regions
and between sexes. Globally, lung cancer has been the
leading cause of cancer deaths among males. However,
breast cancer remained the most frequently diagnosed
cancer in women and the leading cause of cancer death
worldwide, with an estimated 1.7 million new cases and
521,900 deaths in 2012 compared to 1.38 million new
cases and 458,000 deaths in 2008 [1, 2]. This amounts to
25% of all new cancer cases and 15% of all cancer deaths
among females [1, 3–5]. An estimated 231,840 (29%)
new cases of invasive breast cancer were expected to be
diagnosed among women in the US during 2015, com-
pared with 105,590(13%) cases of lung cancer in the
same population [6].
The World Health Organization had estimated that
female breast cancer resulted in a total of 5,884,000 years
of life lost globally during 2004 [7]. This represented just
over 1% of all premature deaths amongst females, ran-
ging from around 8% in parts of Europe to less than
0.5% in Africa [7]. Breast cancer ranked as the fifth cause
of death resulting from cancer overall (522,000) [8].
Global trends suggested increasing incidence in the past
three decades up to 2010, although some developed
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countries recorded trends lower than the global average
[9]. However, over the past two decades, incidence and
mortality trends had remained relatively stable and even
decreasing in many developed countries. On the contrary,
it had been on the rapid increase in many parts of Africa,
Asia, central and South America [7, 10, 11]. The worri-
some aspect however was the fact that while incidence in
the African region (although rising) was lower than in
other continents except Asia, its age-standardized mortal-
ity rate ranked highest globally with Nigeria, the most
populous African nation, having the highest mortality rate.
It has therefore become necessary that the attention of
global and regional policy-makers, researchers and the
general public be drawn to the growing danger that breast
cancer could pose to Africa's development, especially in the
sub-Saharan regions where little attention is being paid on
non-communicable diseases, probably due to the high bur-
den of communicable diseases. It was against this backdrop
that this review was conceived to give an overview of the
global burden of breast cancer with an emphasis on Africa,
its sub-Saharan region and Nigeria. The aim was to high-
light the trends, characteristics, controversies and determi-
nants of rising breast cancer burden in the sub-Saharan
African region and to discuss briefly the implications of this
rising burden to regional development. It must be men-
tioned that sub-Saharan Africa is an extraordinarily large
area in Africa that is economically diverse (see Fig. 7).
Research question
Principally this review aimed to address the following
questions:
1. Is the breast cancer burden in sub-Saharan Africa on
the increase?
2. Are the characteristics and determinants of this
burden clearly ascertained?
3. Will the rising burden of breast cancer pose any
threat to sub-Saharan Africa's regional development?
These were judged by International Agency for Re-
search on Cancer [1] ascertaining whether the available
incidence and mortality figures were increasing over
time; (ii) reviewing the level of consensus on the deter-
minants of Africa's breast incidence among experts; and
(iii) ascertaining whether rising breast cancer burden will
really have any social or economic impact on the region,
and to what extent.
Materials and methods
Search strategy
A literature review of published studies and documents
in Medline, Scopus, PubMed and Google was conducted.
The combinations of keywords-“breast neoplasm,+deve-
loped countries+developing countries, +female incidence
as well as phrases such as ‘global breast cancer inci-
dence’, Burden of breast cancer in Africa, in sub-Saharan
Africa, and in Nigeria”, were used. Google scholar was
used only to search for specific papers identified from
the reference lists of published papers.
Eligibility criteria
Studies included in the review were those published be-
tween January 2000 and May 2016. All publications before
this period were excluded. Studies were included if they
were either peer reviewed or published by Internationally
acknowledged organization such as the World Health
Organization or on websites run by credible organizations.
Such studies also needed to have a relevant title, abstract
and full-text contents.
Study selection
The studies were selected based on the relevance of their
titles, abstract and full-text contents, as summarised in
the chart below (see Fig. 1):
Data extraction
Data were retrieved based on their relevance in explaining
global and regional incidence and mortality patterns. These
were done principally from GLOBOCAN 2012 website and
previously published papers. Maps showing breast cancer
incidence and mortality in Africa, charts on United Nations
world areas in relation to breast cancer incidence and mor-
tality as well as chart showing the incidence and mortality
among the top 20 countries of Africa were based on figures
and analytical tools provided on the GLOBOCAN websites.
The rest of the charts and tables were produced based on
figures retrieved from previously published papers.
Quality assessment
Studies included in this review were only those that met
the set eligibility criteria which were determined prior to
the commencement of this study. The quality, relevance
and application of these studies were assessed by three
independent experts in the field.
Synthesis of results
Data inform of figures on the GLOBOCAN 2012 website
and other previously published papers on breast cancer
burden globally, in Africa and Nigeria were pooled to
develop charts, graphs and tables that guided discussion.
Furthermore, the results, opinions, and conclusions of
previous studies were compared, contrasted and inte-
grated to arrive at opinions, recommendation and conclu-
sions in relation to the objectives of this review.
Results summary
Globally, about 25 and 15% of all new cancer cases and
cancer deaths respectively among females were due to
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breast cancer. Continents in the western world had
higher age-standardized incidence rate of breast cancer
compared to Africa and Asia. However, mortality statis-
tics showed that Africa had the highest age-standardized
mortality rate associated with breast cancer in the world.
The result also provided evidence that the comparatively
low incidence rate of breast cancer in Africa had been
rising over the years. Though southern African sub-region
had the highest incidence rate, western Africa could be
said to have the highest burden when both incidence and
mortality were considered. However, the highest increase
in both incidence and mortality since 2008 were recorded
in eastern and middle African regions. Controversies over
the nature of breast cancer characteristic trend and the
exact determinants were also suggested. There were
evidence that the financial and other possible socioeco-
nomic costs could be very high.
Discussion
The results as subsequently discussed showed that even
though the current assumption that Africa has compara-
tively low incidence rate of breast cancer could be said
to be correct based on available statistics, this incidence
rate is currently on the rise. What is missing most times
in this narrative is the consideration of the possible im-
pact of this seemingly low incidence rate on the National
economies of African sub-regions if left unchecked. This
is even felt more at the local communities and families
who are often not protected socioeconomically by gov-
ernment policies. Breast cancer is like a death sentence
in many African communities and families as shown by
the high mortality rate—the highest in the world. These
communities and families most times mourn and bear this
burden alone as many of these cases do not come to the
attention of national and international policy-makers. It
was this need to draw attention to this rising burden in
relation to its socioeconomic impact on national develop-
ment that made this review necessary.
Overview of global burden of breast cancer and trends
According to a systematic analysis of breast cancer in
187 countries, global breast cancer incidence increased
from 641,000 (95% confidence interval (CI) 610,000–
750,000) cases in 1980 to 1,643,000 (1421000–1,782,000)
cases in 2010, an annual rate of increase of 3.1% [9]. It
was the most frequent cause of cancer death in women
in less developed regions (324,000 deaths, 14.3% of
total), and—after lung cancer—is currently the second
most frequent cause of cancer death in women in more
developed regions (198,000 deaths, 15.4%) [8].
Incidence rates varied across countries with developed
countries of northern America, Australia and New
Zealand having a higher incidence compared to Africa
and Asia [2].
Europe was the continent with the highest breast can-
cer incidence (Fig. 2). In terms of individual countries,
Belgium and Denmark (119.9 and 105.0 per 100,000 re-
spectively) topped the incidence table [4] while region-
ally the highest incidence of breast cancer was in
Fig. 1 Diagrammatic explanation of data extraction process
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northern America and western Europe. The lowest inci-
dence was in eastern Asia and Central America (Fig. 3).
Although incidence rates remained highest in more de-
veloped regions, mortality was relatively much higher in
less developed regions [4]. For example, in northern
America, breast cancer incidence had reached more than
91 new cases per 100,000 women annually, compared with
27 per 100,000 in middle Africa. In contrast, breast cancer
mortality rates in these two regions were almost identical,
at about 15 per 100,000 [12]. While more developed coun-
tries account for about one-half of all breast cancer cases,
they record only 38% of deaths [1, 5].
Literature suggested that trends in incidence varied with
age and ethnicity in different populations. For example, it
had been reported that women of reproductive age were
twice as likely to develop breast cancer in developing
countries as in developed countries, while more than two-
thirds of cases in developed countries occurred in women
of age 50 years and above [9]. In the USA, the breast can-
cer incidence rate decreased almost 7% among white
women from 2002 to 2003 and remained stable from 2007
to 2011. However, it increased by an annual rate of 0.3%
among black women between 2007 and 2011 [6]. Ethnic
differences in mortality rates had also been reported in
the USA, probably related to poor insurance coverage
among ethnic minorities [13]. In addition, differences
in age at breast cancer diagnosis by ethnicity had
been reported in a number of countries, including
Sweden [14] and Iraq [15] with immigrants and Kurds
exhibiting earlier mean age at diagnosis than their
matched Swedish and USA controls respectively.
Breast cancer incidence and trends in sub-Saharan Africa
It was difficult to estimate exactly the incidence of
cancer including that of breast in Africa. In the former
volume (volume ix) of WHO publication on global inci-
dence of breast cancer, data from only 5 out of the 14
African countries that submitted data were found ac-
ceptable, due to poor quality and incompleteness. This
represented 31% (5/16) of cancer registries and covered
only 1% (8.8 million) of the population [16]. The recent
publication (volume x) recorded only an additional three
countries [17].
However, recent incidence data from registries in
Uganda, Zimbabwe, the Gambia, and Mali between 1991
and 2010 [18–21] as well as GLOBOCAN figures (see
Fig. 4a–c) provided strong evidence to suggest that
breast cancer incidence in sub-Saharan Africa was on
the increase. In Zimbabwe, for example, a 4.5% annual
increase in incidence over the period 1991–2010 had
been reported [20]. It should be reminded that these
were only recoded incidents.
There was substantial variation in estimated breast
cancer incidence across different African regions in
2012. Estimates of age-standardized incidence rates (per
100,000 women per year) as shown in Fig. 2a were 30.4
in eastern Africa, 26.8 in middle Africa, 38.6 in western
Africa, and 38.9 in southern Africa [1, 18]. Hence, the
rate was lowest in Middle Africa (26.8) and highest in
southern Africa (38.9), probably due to high population
of whites with higher exposure to economic and
reproductive risk factors [22, 23]. With an average inci-
dence of 33.7 per 100,000 women per year, sub-Saharan
Fig. 2 Global burden of breast cancer by continents (per 100,000 women per year)(based on Ferlay et al. [8]). Figure 2 was based on seven
continent model [65]. Central America and Caribbean were grouped under northern America, while New Zealand, Polynesia and Micronesia were
grouped under Australia. It showed that while continent of Europe had the highest ASR incidence rate, Africa had the highest ASR mortality rate.
This may differ slightly when analysis is based on United Nation’s world areas shown
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Africa tended to have a lower incidence rate compared
to North Africa (43.2 per 100,000 women per year) [12].
However, country wise, the sub-Saharan African coun-
tries—Mauritius (64.2 per 100,000 women) and Nigeria
(50.5 per 100,000 women) in eastern and western Africa
respectively were ranked first and second in incidence
ahead of Egypt (49.50 per 100,000 women) the highest
ranked country of northern Africa, which occupied the
third position [12]. In sub-Saharan Africa, breast cancer
incidence (33.8 per 100,000 women per year) currently
ranks only second to cervical cancer incidence (34.8 per
100,000 women per year), with only a small difference
between these rates. Yet, this was not applicable to all
the four regions of sub-Saharan Africa. Breast cancer in-
cidence in western Africa in 2012 was 20.1 per 100,000
women per year compared to 18.5 per 100,000 women
Fig. 3 Breast Cancer Burden by United Nations world areas. The figure shows that while northern America has the highest incidence rate,
western Africa has the highest mortality rate
Azubuike et al. World Journal of Surgical Oncology  (2018) 16:63 Page 5 of 13
per year for cervical cancer. The gap was even more in
southern Africa with 38.9 breast cancer cases per
100,000 women per year. The incidence rate for cervical
cancer in southern Africa that same year was 31.5 cer-
vical cancer cases per 100,000 women per year [12].
More disturbing was the suggestion that in contrast to
the comparatively low incidence rate in Africa, the
mortality rate might be disproportionately 50% higher
relative to incidence rate [24, 25]. In comparison to
other continents of the world, the age-standardized inci-
dence rate of breast cancer for the African continent
had been estimated to be the lowest (36.2 per 100,000
women per year) except for Asia (29.1 per 100,000
women per year). Yet, its age-standardized mortality rate
(17.3 per 100,000 women per year) ranked higher than
every other continent or region of the world. Though
the region was projected to contribute 6.79% of the glo-
bal incidence projection by 2030, it was estimated it
would contribute a disproportionate 10% of the total
mortality projected [12]. Sub-Saharan African data ac-
cording to GLOBOCAN 2012 [12] showed that the
highest age-standardized mortality rate was in western
Fig. 4 a Distribution of breast cancer incidence and mortality in Africa (based on GLOBOCAN, 2012). b Map of Africa showing distribution of
age-standardized incidence rates by countries. c Map of Africa showing distribution of age-standardized mortality rates by countries
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Africa (20.1 per 100,000 per year). This might be related
to the high mortality rate in Nigeria. Middle Africa
maintained the lowest position (14.9 per 100,000 per
year) while eastern Africa had a rate of 15.6 per 100,000
per year. In consistent with the incidence trend, al-
though cervical cancer remained the leading cause of
cancer death among women in sub-Saharan Africa,
breast cancer has remained the leading cause of death
among women in the West African sub-region with an
age-standardized mortality rate of 20.1 per 100,000
women per year in 2012 compared to 18.5 per 100,000
women per year for cervical cancer [14]. Breast cancer
might constitute a higher threat to improved access to
health care especially among women in sub-Saharan Af-
rica if no action is taken.
It is important to note that even the comparatively
lower incidence and mortality rates observed in eastern
and Middle Africa might not imply a lower risk in its
true sense. Table 1 suggested that the percentage in-
creases in the annual standardized rate (ASR) for inci-
dence and mortality between 2008 and 2012 were higher
in those regions compared to southern and western Af-
rica. This gives a cause for concern in the light of the
fact these regions still had the highest incidence and
mortality recorded for another important female cancer-
cervical cancer. It was not quite clear whether this could
be attributed to improved detection or increasing expos-
ure to risk. Southern Africa was the only region with a
comparatively stable incidence rate and interestingly a
remarkable reduction in age-standardized mortality rate
(Table 1). This might be associated probably with an
influence from improved health care systems and better
insurance coverage in South Africa. The reduction in
mortality rate in South Africa as observed by Cubash et
al. [26] could also reflect improvement in life expectancy
resulting from recorded improvement in HIV/AIDs
treatment especially among breast cancer patients infected
by the virus.
Incidence trend characteristics and controversies
Existing evidence suggested that breast cancer in Africa
tended to occur in relatively younger age groups and among
premenopausal women compared to the western population
[21, 27–31]. For example, a low mean age of 48 years among
Nigerians and a median age of 46 years among blacks com-
pared to 67 years among white British women had been re-
ported [28, 32]. However, recent reports seemed to suggest a
changing trend with higher incidence being reported among
older and postmenopausal women [18–20], probably due to
a changing demographic trend. Late presentation and ad-
vance stage distribution was common [27, 33, 34]. There had
been suggestions of the existence of a possible inherently ag-
gressive tumours biology similar to those observed among
African American women [33, 35]. However, in the view of
Akarolo-Anthony et al. [36], the dominant young age profile
of cases, the predominant aggressive clinical course, and the
high fatality rate that characterized African breast cancer
cases might reflect the demographic structure of the African
population (which tends to be younger) rather than intrinsic
biological vulnerability as had been suggested [36]. They also
queried the suggestion that African breast tumours were
predominantly receptor poor, attributing it to possible prob-
lems arising from poor preparation and fixation of tissue
samples, as well as lack of methodological standardization is-
sues observed earlier by Adebamawo et al. [37]. However,
the results of breast cancer trend analyses between 1987 and
2009 in Mali and Gambia by Sighko et al. [21] could not at-
tribute the increase in incidence of pre-menopausal breast
cancer recorded in that study to changes in life expectancy
and population structure. They argued that while a small but
significant shift in incidence towards older age for other
cancers such as stomach cancer in women of the same
population was observed, occurrence of breast cancer was
dominantly among younger people (< 50–55 years). It
seemed therefore that the picture of breast cancer incidence
in Africa is still unfolding, and it might take some time
before a valid conclusion could be drawn. There is a need
for the promotion of more quality studies in order to deter-
mine exactly the true picture of breast cancer incidence in
sub-Saharan Africa and by extension the entire continent.
Determinants of the rising incidence of breast cancer in
Africa
One key factor that had been implicated in the increas-
ing incidence of breast cancer in Africa and Nigeria in
particular was the increasing adoption of westernized
lifestyle and behaviours resulting in changes in diet, later
age of reproduction and reduction in physical activity
among the African population [2, 19, 20, 33]. This
seemed to have been associated with rural-urban drift
and socioeconomic improvement, as well as other
urban-related changes that might have altered pre-
existing protective characteristics of such cities; such as
Table 1 Estimated changes in ASR between 2008 and 2012
(computed based on Ferlay et al. 2008 [2] and 2012 [12] figures)
Sub-regions Incidence Mortality
2008 2012 %increase 2008 2012 % increase
Eastern Africa 19.3 30.4 36.5 11.4 15.6 26.9
Middle Africa 21.3 26.8 20.5 13.1 14.9 12.1
Northern Africa 32.7 43.2 24.3 17.8 17.4 − 2.3
Southern Africa 38.1 38.9 2.0 19.3 15.5 − 24.5
Western Africa 31.8 38.6 17.6 19.0 20.1 5.5
The table suggested that while higher age-standardized incidence and mortality
rates remained higher in southern and western African sub-regions in both years,
higher increases in both incidence and mortality rates were observed in eastern
(36.5 and 26.9%, respectively) and middle (20.5 and 12.1%, respectively) Africa in
2012 compared to 2008. Southern Africa had a comparatively more stable
incidence rate (only 2% increase) and interestingly a remarkable decrease
in mortality rate
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consumption of traditional and unprocessed foods, in-
creased physical activity, and low exposure to carcino-
gens [38].
Some experts had attributed the rising incidence to in-
creasing population and life expectancy with many Afri-
can women living long enough for the disease to
manifest [36, 39]. It had also been suggested that it
might reflect a growing awareness of breast cancer and
change in health seeking behaviours, as well as improve-
ment in screening and diagnostics technology. However,
many studies had reported poor awareness and poor
availability of screening services, diagnostic skills and
technology [7, 40]. While it may be obvious that the
answer lies in a combination of these factors acting at
various levels of the society, determining the differen-
tial contribution of each factor is necessary for the
purpose of prioritizing intervention in the face of
scarce resources. It might be against this backdrop
that Sigko et al. had suggested that due to the con-
flicting results and controversies, further studies were
needed in the region to determine whether this in-
creasing trend could be associated with changes in re-
productive, nutritional and environmental risk factors
or sociological changes that might have increased
awareness, recognition and diagnosis of the disease
[21]. This suggestion is unarguably very timely and
demands a sense of obligation on the part of Inter-
national and national policy-makers as well as re-
searchers in the region.
Nigeria scene
Advanced stage distribution characterised the presenta-
tion of breast cancer in Nigeria like other parts of Africa,
with more than 70% presenting at stage III or IV in
some cases [27, 29, 33, 41] compared to ≤ 46% in Europe
[32, 42]. This had been attributed to late presentation
and delay in seeking treatment [33].
The population of Nigeria not only plays a major
role in the incidence records of sub-Saharan Africa,
but also provides an opportunity for reduction of
breast cancer incidence and mortality in the region.
Nigeria is the most populous country in Africa, with
approximately 20% of the continent’s population and
slightly more than half that of West Africa [39, 43].
It was therefore not surprising that of the estimated
681,000 new cases of cancer that occurred in Africa
in 2008, Nigeria contributed 15% [43], with about
100,000 new cases of cancer occurring every year [2].
This figure likely underrepresented the true number
of incident cases of breast cancer since they were
mostly based on reports from medical institutions as
opposed to incidence studies; nonetheless, this sug-
gested that a substantial reduction in the breast can-
cer burden for all of sub-Saharan Africa could be
achieved if breast cancer burden in Nigeria is
reduced.
Nigeria, like other African countries, suffers from the
problem of data unavailability. For example, of the eight
volumes of estimates produced by WHO on cancer inci-
dence globally, Nigeria only featured in the first three,
with the last being volume III (1960–1969) [16]. How-
ever, Okobia et al. [44] reported that incidence doubled
from 15.3 per 100,000 in 1976 to 33.6 per 100,000 in
1993 with a proviso that this might be an underestimate.
A recent analysis of two population-based breast cancer
registries covering 2.5% of Nigerian population, aimed at
determining the cumulative incidence rate from 2009 to
2010, had been reported [39]. The combined ASR of
breast cancer incidence from both registries was 54.3
per 100,000 per year compared to combined ASR of cer-
vical cancer incidence of 34.5 per 100,000 per year. Cer-
vical cancer was the second most common female
cancer diagnosed in the country. According to the au-
thors, while the incidence of cervical cancer remained
relatively stable, there was a significant increase in the
incidence of breast cancer compared to historical re-
cords (13.7 per 100,000 women per year for 1960–1969,
24.7 per 100,000 women per year between 1998 and
1999 as shown in Fig. 5 [39, 45]). These data there-
fore suggested an approximate increase by 80.3% over
the four decades and an increase of approximately
20.1% per decade. The recent ASR of 54.3% reported
[39] equates to approximately a 120% increase be-
tween the years 2000 and 2010. The figure was higher
than the GLOBOCAN estimate for 2008 (38.7 per
100,000), although the extent of generalizability might be
questioned [39]. Interestingly, the current age-
standardized rate, as published by GLOBOCAN in
2012, was 50.5 per 100,000 women per year, placing
Nigeria second only to Mauritius (64.2 per 100,000)
in Africa.
The most worrisome aspect of this development was
the fact that even though Nigeria was ranked second in
terms of breast cancer incidence, its age-standardized
mortality ratio was the highest in Africa (25.9 per
100,000, compared to 18.8 per 100,000 for Mauritius)
(see Fig. 6). Among other factors, the growing cases of
breast cancer in Nigeria seemed to have been worsened
by the steeply increasing size of the population at risk
from approximately 24.5 million in 1990 to approxi-
mately 40 million in 2010 and was projected to rise to
over 50 million by 2020 [36]. Breast cancer in Nigeria
shares similar assumptions that characterise the sub-
Saharan African region, i.e. breast cancer cases with late
presentation, younger patients and aggressive tumours
[34, 44], though these characteristics were still subject to
debate. There is an urgent need, therefore, to identify
precisely the prevalent risk factors, biological, social and
Azubuike et al. World Journal of Surgical Oncology  (2018) 16:63 Page 8 of 13
environmental circumstances driving the increasing inci-
dence of breast cancer in Nigeria.
Implications for regional development
Breast cancer burden will certainly aggravate Africa’s
health, socioeconomic and other developmental prob-
lems unless action is taken to reduce it. While the con-
tinent is still grappling with the burden of infectious
diseases, child and maternal deaths (which constitute
the top targets for the region in the global effort towards
achieving millennium development goals), chronic non-
communicable diseases such as cancer are now becom-
ing an increasing threat. The rising burden of non-
communicable diseases, including breast cancer, if not
tackled in time will overwhelm the coping capacities of
African countries which are currently struggling with in-
fectious diseases [46–48].
Cancer had been said to have a greater economic im-
pact than all other diseases with lung cancer, colorectal
cancer and breast cancer on the lead [49]. This is bad
news for poorly funded health sectors of the African
continent [50]. The rising incidence of breast cancer
particularly in sub-Saharan Africa deserves urgent atten-
tion. It should be noted that breast cancer had been pro-
jected to exceed cervical cancer incidence rate in the
entire region by 2030 (162,419 new cases compared to
160,163 new cases of cervical cancer) [12]. Experience
from within and outside the continent [51–54] strongly
suggested that the cost of treating breast cancer is much
more than an average household and society in Africa
can afford. Although there had not been many studies
on the socioeconomic impact of the disease in sub-
Saharan African, a 2009 study in Ibadan, Nigeria re-
ported about 85% of those diagnosed with breast cancer
were income earners, and of this 70% had an annual in-
come of less than 12,500.00 Nigerian Naira (~ 100USD)
[55]. An expert opinion in 2013 reported by one of
Nigeria’s leading news dailies showed that a running bill
of 150,000–350,000 Nigerian naira (~ $962–$2244, $1 =
N156) accumulates for patients every 3 weeks [56]. This
was substantially higher than the average income of a
Nigerian middle class earner (NGN75, 000–100,000
($480–645) as well as the national minimum monthly
wage of N18, 000($115.4) [57]. The treatment cost in
reference was based in Nigerian standard of clinical care.
In the USA, individual lifetime lost earnings of $1.10
million had been reported [51] while the estimates of
lifetime per-patient direct medical care costs of breast
cancer ranged from $US20 000 to $US100000 or more
[54, 58]. In Australia, annual household income dropped
by $12,000 following breast cancer diagnosis [53]. It is
therefore beyond doubt that breast cancer would cer-
tainly increase the problem of poverty by depleting
household and individual resources in sub-Saharan Afri-
ca—a situation that will be worsened by poor or non-
existing health insurance for citizens.
Furthermore, the accumulating evidence that breast
cancer tends to affect women of higher educational, eco-
nomical and professional status [59–61] implies that de-
lays in tackling breast cancer could take its toll on the
region’s female workforce, especially those holding im-
portant societal positions thereby widening the gender
gap in employment. It would also constitute a big dis-
traction to their spouses and other family members who
might be serving in various strata of the labour force.
This would have serious economic consequences. Judg-
ing by the total lost productivity cost in advanced coun-
tries [51], the economic consequence will take its toll on
the already struggling gross domestic product of many
African countries. Breast cancer could become another
big obstacle to female education in the African contin-
ent, as many young females might be taken out of school
to either attend to their ailing mothers or take up some
of the roles that their mothers might no longer be able
Fig. 5 Increasing incidence of breast cancer in Nigeria since 1960 (based on Jeddy Egba etal [38] and GLOBOCAN, 2012 [12]
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to perform due to illness or death [53, 62]. These socio-
economic consequences will be compounded because
the sub-Saharan Africa breast cancer cases profile based
on available data showed that affected women tended to
be younger in age [33, 34]. The economic implication of
the disease had been shown to be worse in younger than
in old women [52]. The consequence on maternal health
will further aggravate the problem of child and infant
mortality [63] which is already a big problem in the
region.
The high mortality associated with breast cancer in
Africa provides clear evidence that the region does not
yet have appropriate treatment strategies in place. There
was also clear evidence that Africa cannot cope if it
allows its current incidence rates to reach the figures of
the developed countries of Europe and America. In light
of the above, a key line of action for African countries
should be to prevent the disease before it happens,
through proper identification and exposure reduction to
established risk factors; as well as early diagnosis and
timely treatment [64].
The key question is ‘how can these happen when there
are few or no indigenous studies to authenticate the key
risk factors involved and the level of risk they pose?’ It is
therefore strongly recommended that while efforts for
improved diagnosis and treatment continue, research
studies should be initiated to identify accurately the risk
factors and conditions playing a role in the rising
Fig. 6 Top 20 countries with the highest incidence and Mortality associated with breast cancer in Africa
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incidence of breast cancer in sub-Saharan Africa (Fig. 7).
This will inform the prioritization of interventions in the
context of scarce resources.
A possible limitation to this review relates to the gen-
eral problem of data availability and challenges faced by
studies from developing countries. Data availability and
good record keeping is a big problem in many African
countries. Furthermore, conducting quality research in
many African countries is challenging due to poor fund-
ing and policy priorities. On the other hand, there seems
to be a general consensus among experts that the prob-
lem of data unavailability tends to result more in
underestimation than overestimation of the problem.
This therefore could further strengthen the concerns of
this paper. The study strengths further lie in its wide in-
clusion and elaborate review of key and relevant litera-
ture currently available in sub-Saharan Africa.
Conclusion
This review demonstrates that investment in research to
guide interventions for the control of breast cancer in
sub-Saharan Africa will have a far-reaching effect. It will
help in preserving the gains already made in reduction
of child and maternal mortality while sustaining the
Fig. 7 Map of Africa showing sub-Saharan Africa (countries below the grey area). (Source: https://www.librarything.com/topic/183039)
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increasing access to girl/female education in the contin-
ent. The avoided social and economic cost will certainly
have an unquantifiable benefit to the national develop-
ment of African countries.
Moreover, the control of breast cancer will provide a
great opportunity for further reduction of the existing prob-
lem of cervical cancer [64] in sub-Saharan Africa as well as
the control of other cancers and non-communicable dis-
eases (e.g. cardiovascular diseases) known to share similar
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